There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Omnicell (OMCL – Research Report), Haemonetics (HAE – Research Report) and CVRx (CVRX – Research Report) with bullish sentiments.
Omnicell (OMCL)
In a report released today, Matt Hewitt from Craig-Hallum maintained a Buy rating on Omnicell, with a price target of $50.00. The company’s shares closed last Thursday at $29.24, close to its 52-week low of $28.76.
According to TipRanks.com, Hewitt is ranked 0 out of 5 stars with an average return of
The word on The Street in general, suggests a Moderate Buy analyst consensus rating for Omnicell with a $41.50 average price target, a 37.2% upside from current levels. In a report released today, Piper Sandler also upgraded the stock to Buy with a $39.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Haemonetics (HAE)
Barrington analyst Michael Petusky maintained a Buy rating on Haemonetics today and set a price target of $105.00. The company’s shares closed last Thursday at $85.46.
According to TipRanks.com, Petusky is a 4-star analyst with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for Haemonetics with a $107.25 average price target, which is a 22.0% upside from current levels. In a report released today, JMP Securities also reiterated a Buy rating on the stock with a $115.00 price target.
CVRx (CVRX)
Craig-Hallum analyst Alexander Nowak maintained a Buy rating on CVRx today. The company’s shares closed last Thursday at $13.62.
According to TipRanks.com, Nowak is currently ranked with 0 stars on a 0-5 stars ranking scale, with an average return of
The word on The Street in general, suggests a Strong Buy analyst consensus rating for CVRx with a $18.75 average price target, a 36.2% upside from current levels. In a report issued on October 27, Canaccord Genuity also maintained a Buy rating on the stock with a $16.00 price target.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
Read More on OMCL:
